319 related articles for article (PubMed ID: 11356512)
41. Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha 2-macroglobulin receptor in antigen presentation by monocytes.
Morrot A; Strickland DK; Higuchi Mde L; Reis M; Pedrosa R; Scharfstein J
Int Immunol; 1997 Jun; 9(6):825-34. PubMed ID: 9199965
[TBL] [Abstract][Full Text] [Related]
42. Modulation of the catalytic activity of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, by temperature and pH.
Salvati L; Mattu M; Polticelli F; Tiberi F; Gradoni L; Venturini G; Bolognesi M; Ascenzi P
Eur J Biochem; 2001 Jun; 268(11):3253-8. PubMed ID: 11389727
[TBL] [Abstract][Full Text] [Related]
43. Polymorphisms of the genes encoding cruzipain, the major cysteine proteinase of Trypanosoma cruzi, in the region encoding the C-terminal domain.
Martínez J; Henriksson J; Ridåker M; Pettersson U; Cazzulo JJ
FEMS Microbiol Lett; 1998 Feb; 159(1):35-9. PubMed ID: 9485592
[TBL] [Abstract][Full Text] [Related]
44. Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase.
Murta AC; Persechini PM; Padron Tde S; de Souza W; Guimarães JA; Scharfstein J
Mol Biochem Parasitol; 1990 Nov; 43(1):27-38. PubMed ID: 1705310
[TBL] [Abstract][Full Text] [Related]
45. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
[TBL] [Abstract][Full Text] [Related]
46. Structural determinants of specificity in the cysteine protease cruzain.
Gillmor SA; Craik CS; Fletterick RJ
Protein Sci; 1997 Aug; 6(8):1603-11. PubMed ID: 9260273
[TBL] [Abstract][Full Text] [Related]
47. Proteolytic cleavage of chemokines by Trypanosoma cruzi's cruzipain inhibits chemokine functions by promoting the generation of antagonists.
Benítez-Hernández I; Méndez-Enríquez E; Ostoa P; Fortoul T; Ramírez JA; Stempin C; Cerbán F; Soldevila G; García-Zepeda EA
Immunobiology; 2010 May; 215(5):413-26. PubMed ID: 19581017
[TBL] [Abstract][Full Text] [Related]
48. Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review.
Duschak VG; Couto AS
Curr Med Chem; 2009; 16(24):3174-202. PubMed ID: 19689291
[TBL] [Abstract][Full Text] [Related]
49. Trypanosoma cruzi: partial characterization of minor cruzipain isoforms non-adsorbed to Concanavalin A-Sepharose.
Duschak VG; Barboza M; Couto AS
Exp Parasitol; 2003; 104(3-4):122-30. PubMed ID: 14552859
[TBL] [Abstract][Full Text] [Related]
50. Molecular modeling and substrate specificity of discrete cruzipain-like and cathepsin L-like cysteine proteinases of the human blood fluke Schistosoma mansoni.
Brady CP; Brinkworth RI; Dalton JP; Dowd AJ; Verity CK; Brindley PJ
Arch Biochem Biophys; 2000 Aug; 380(1):46-55. PubMed ID: 10900131
[TBL] [Abstract][Full Text] [Related]
51. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.
Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF
Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554
[TBL] [Abstract][Full Text] [Related]
52. Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and
Boudreau PD; Miller BW; McCall LI; Almaliti J; Reher R; Hirata K; Le T; Siqueira-Neto JL; Hook V; Gerwick WH
J Med Chem; 2019 Oct; 62(20):9026-9044. PubMed ID: 31539239
[TBL] [Abstract][Full Text] [Related]
53. The C-terminal extension of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi.
Aslund L; Henriksson J; Campetella O; Frasch AC; Pettersson U; Cazzulo JJ
Mol Biochem Parasitol; 1991 Apr; 45(2):345-7. PubMed ID: 2038364
[No Abstract] [Full Text] [Related]
54. Inhibition of cruzipain, the major cysteine proteinase of the protozoan parasite, Trypanosoma cruzi, by proteinase inhibitors of the cystatin superfamily.
Stoka V; Nycander M; Lenarcic B; Labriola C; Cazzulo JJ; Björk I; Turk V
FEBS Lett; 1995 Aug; 370(1-2):101-4. PubMed ID: 7649285
[TBL] [Abstract][Full Text] [Related]
55. Trypanosoma cruzi: cruzipain and membrane-bound cysteine proteinase isoform(s) interacts with human alpha(2)-macroglobulin and pregnancy zone protein.
Ramos AM; Duschak VG; Gerez de Burgos NM; Barboza M; Remedi MS; Vides MA; Chiabrando GA
Exp Parasitol; 2002 Feb; 100(2):121-30. PubMed ID: 12054702
[TBL] [Abstract][Full Text] [Related]
56. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections.
Martinez J; Campetella O; Frasch AC; Cazzulo JJ
Infect Immun; 1991 Nov; 59(11):4275-7. PubMed ID: 1937786
[TBL] [Abstract][Full Text] [Related]
57. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of the secretory pathway in cysteine protease inhibitor-resistant Trypanosoma cruzi.
Engel JC; Torres C; Hsieh I; Doyle PS; McKerrow JH
J Cell Sci; 2000 Apr; 113 ( Pt 8)():1345-54. PubMed ID: 10725218
[TBL] [Abstract][Full Text] [Related]
59. Cruzain : the path from target validation to the clinic.
Sajid M; Robertson SA; Brinen LS; McKerrow JH
Adv Exp Med Biol; 2011; 712():100-15. PubMed ID: 21660661
[TBL] [Abstract][Full Text] [Related]
60. Purification and preliminary sequencing of Tc-45, an immunodominant Trypanosoma cruzi antigen: absence of homology with cruzipain, cruzain, and a 46-kilodalton protein.
Aguillon JC; Bustos C; Vallejos P; Hermosilla T; Morello A; Repetto Y; Hellman U; Orn A; Ferreira A
Am J Trop Med Hyg; 1995 Aug; 53(2):211-5. PubMed ID: 7677227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
